Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer

The study confirms the importance of analyzing prognostic variables separately within BC subtypes, highlights the advantages of using metagenes rather than genes, and finally identifies in node-negative ESR1+/ERBB2− BCs, the unfavorable role of high IFN metagene expression.